Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.8.0.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2018
Stockholders' Equity [Abstract]  
Schedule of stock-based compensation

 

    For the Three Months Ended March 31,  
    2018     2017  
 Research and development   $ 773,659     $ 66,693  
 General and administrative     205,049       347,820  
 Total   $ 978,708     $ 414,513  
Schedule of stock option activity
                Weighted Average        
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2017     5,691,414       3,124,941     $ 1.16     $ 0.73     $ 0.73       6.87     $ -  
Granted     280,000       -       -       -       -       -       -  
Exercised     (249,309 )     -       -       -       -       -       -  
Cancelled     -       -       -       -       -       -       -  
Balance – March 31, 2018     5,722,105       3,191,721     $ 1.41     $ 0.84     $ 0.84       6.73     $ 19,706,706
Schedule of stock options outstanding and exercisable
            Weighted   Weighted        
Exercise     Number     Average Remaining   Average     Number  
Price     Outstanding     Contractual Term   Exercise Price     Exercisable  
                         
$ 0.05       52,876     4.01 years   $ 0.05       52,877  
$ 0.26       915,497     6.03 years   $ 0.26       915,497  
$ 0.73       1,381,691     6.62 years   $ 0.73       1,135,743  
$ 1.00       287,124     7.31 years   $ 1.00       200,457  
$ 1.10       8,000     7.78 years   $ 1.10       3,833  
$ 1.17       31,605     7.62 years   $ 1.17       6,605  
$ 1.22       70,312     7.85 years   $ 1.22       13,021  
$ 1.50       28,000     7.92 years   $ 1.50       8,834  
$ 1.55       1,456,000     7.94 years   $ 1.55       566,000  
$ 2.02       85,000     9.36 years   $ 2.02       40,000  
$ 2.40       926,000     8.84 years   $ 2.40       145,833  
$ 4.60       200,000     9.69 years   $ 4.60       12,500  
$ 5.30       280,000     9.99 years   $ 5.30       90,521  
  Totals       5,722,105                   3,191,721
Schedule of warrants activity
                Weighted Average        
    Warrants     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2017     4,533,020       4,517,395     $ 1.85     $ 1.85     $ 1.00       3.21     $ -  
Granted     428,500       -       -       -       -       -       -  
Exercised     (267,333 )     -       -       -       -       -       -  
Cancelled     -       -       -       -       -       -       -  
Balance – March 31, 2018     4,694,187       4,694,187     $ 2.14     $ 2.14     $ 1.12       2.99     $ 14,977,413